PCM
MYOK

Piermont Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Piermont Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,930
Closed -$245K – 240
2018
Q2 		$245K Sell
4,930
-860
-15% -$41.6K 0.08% 222
2018
Q1 		$283K Sell
5,790
-870
-13% -$45.2K 0.09% 223
2017
Q4 		$280K Buy
+6,660
New +$257K 0.09% 220

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Piermont Capital Management's MYOK Position: Q3 2018 in Review

Piermont Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2018, closing a stake of 4,930 shares — an estimated $245K sold.

Piermont Capital Management first reported a position in MYOK in Q4 2017 and held it in 3 quarters. The position peaked at $283K in Q1 2018. 125 funds tracked by Wall St. Rank hold MYOK as of Q3 2018.

  • Piermont Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Piermont Capital Management sold 4,930 MyoKardia, Inc. Common Stock shares in Q3 2018, an estimated $245K.
  • Piermont Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
  • Piermont Capital Management's MyoKardia, Inc. Common Stock position peaked at $283K in Q1 2018.
  • 125 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2018.

Based on Piermont Capital Management's 13F filing for Q3 2018, filed 6 Nov 2018.